| Detected | Trial | Change |
|---|---|---|
| 2026-06-02 | NCT07601100 Phase 1b/2: Isatuximab, Iberdomide, Bortezomib, Dexamethasone in Transplant… |
Primary endpoint(s) modified |
| 2026-06-02 | NCT07601100 Phase 1b/2: Isatuximab, Iberdomide, Bortezomib, Dexamethasone in Transplant… |
Trial arms changed: 2 -> 6 |
| 2026-05-23 | NCT05225428 Video Education With Result Dependent dIsclosure |
date change Primary completion pushed: 2026-04-30 -> 2026-08-30 |
| 2026-05-23 | NCT05225428 Video Education With Result Dependent dIsclosure |
date change Completion pushed: 2026-09-01 -> 2026-10-01 |
| 2026-05-15 | NCT04789486 Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and… |
date change Completion pushed: 2028-09-10 -> 2030-04-10 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-03 | NCT07624513 Determination 2 - Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction… | Phase 3 | Not Yet Recruiting |
| 2026-05-22 | NCT07601100 Phase 1b/2: Isatuximab, Iberdomide, Bortezomib, Dexamethasone in Transplant… | Phase 1/2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07426484 | Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy | Cutaneous Squamous Cell Carcinoma | Not Yet Recruiting |
| Phase 3 | |||
| NCT03020030 | Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents | Acute Lymphoblastic Leukemia, Pediatric | Active, Not Recruiting |
| NCT07624513 | Determination 2 - Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction… | Multiple Myeloma | Not Yet Recruiting |
| Phase 2 | |||
| NCT06366347 | ALPINE: Maintenance Letrozole/Abemaciclib | Endometrial Cancer | Recruiting |
| NCT07397611 | Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC | Renal Cell Carcinoma | Recruiting |
| NCT07465276 | Neoadjuvant Ficerafusp Alfa With Pembrolizumab in Resectable SCC | Head and Neck Squamous Cell Carcinoma (HNSCC) | Recruiting |
| NCT04620187 | Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas | Salivary Gland Cancer | Recruiting |
| NCT07123649 | Individualizing Approaches to Surveillance Mammography in Older Breast Cancer Survivors… | Breast Cancer | Recruiting |
| NCT04893109 | ATEMPT 2.0: Adjuvant T-DM1 vs TH | Breast Cancer | Recruiting |
| NCT03310879 | Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations… | Cancer | Recruiting |
| NCT04468061 | Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC | Breast Cancer | Recruiting |
| NCT04434040 | Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA) | Breast Cancer | Recruiting |
| NCT07434843 | PH 2 Pemigatinib in SDH-deficient GIST | SDH Gene Mutation | Recruiting |
| NCT07467772 | Ph 2 Elacestrant in ER Positive Uterine Sarcomas | Uterine Sarcoma | Recruiting |
| NCT05922761 | BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP) | Bronchiolitis Obliterans Syndrome | Recruiting |
| NCT00165256 | Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast | Ductal Carcinoma in Situ of the Breast | Active, Not Recruiting |
| NCT03668340 | AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine… | Uterine Cancer | Active, Not Recruiting |
| NCT02653755 | The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II… | Breast Cancer Radiation | Active, Not Recruiting |
| NCT06001762 | TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer | Breast Cancer | Active, Not Recruiting |
| NCT03333616 | Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors | Genitourinary Cancer | Active, Not Recruiting |
| NCT02648997 | An Open-Label Phase II Study of Nivolumab or Nivolumab/Ipilimumab in Adult Participants… | Meningiomas | Active, Not Recruiting |
| NCT02919683 | Window Study of Nivolumab With or Without Ipilimumab in Squamous Cell Carcinoma of the… | Head and Neck Cancer | Active, Not Recruiting |
| NCT02876302 | Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative… | Inflammatory Breast Cancer (IBC) | Active, Not Recruiting |
| NCT01574274 | SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and… | Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| NCT04938232 | Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL | Hodgkin Lymphoma | Active, Not Recruiting |